Clinical Trial Update: Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Nordic Study evaluating outcomes in heart and lung transplant recipients in relation to cyclosporine microemulsion C2 level…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Lung Transplant

Drugs mentioned

• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart and Lung Transplant | Phase 4 | Status: COMPLETED